It's the turn of the pharmaceutical and medical firms to take a hit on the FTSE 100, as GlaxoSMithKline, Smith & Nephew and Alliance Unichem suffered falls by close of business in London.
The FTSE 100 index sustained the losses relatively well – partly because the markets had managed to stay afloat for most of the day – and closed up just 1.8 points at 4,571.8 as GSK ended down 21p or 1.79% to £11.51 and Smith & Nephew, seller of orthopedic devices, dropped 7.5p or 126% to 588p. Alliance Unichem eventually ended the day off 6.5p or 1.06% to 606p. Other stocks to make an impact included BAE Systems which gained 5p or 2.32% to 220.5p while publishing firm EMAP gained 25p or 2.89% to 899p. Xstrata, the mining company, also closed the day up 12p or 1.77% to 689p. In the...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes